Concord Biotech Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '24
Sep '24
Jun '24
Mar '24
Dec '23
Total Qtr Revenue cr
258.95
320.21
226.11
329.78
248.98
Other Income Qtr Cr14.7310.0310.3110.818.19
Operating Revenues Qtr244.22310.18215.80318.97240.80

*All values are in Cr.

Operating Expenses Qtr
146.27
173.50
134.52
184.68
134.87
Operating Profit Qtr
97.95
136.68
81.28
134.29
105.93
EBIDT Qtr Cr
112.68
146.70
91.59
145.10
114.12
Depreciation Qtr
13.26
13.31
13.18
13.72
13.54
Net Profit Qtr
75.92
95.74
59.59
95.02
77.57
Basic EPS Qtr
7.26
9.15
5.70
9.08
7.41
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -